CN Patent
CN101918360A — 具有1-磷酸-鞘氨醇(s1p)受体生物学活性的带芳基或者杂芳基基团的吲哚化合物
Assigned to Allergan Inc · Expires 2010-12-15 · 15y expired
What this patent protects
本发明提供可用作1-磷酸-鞘氨醇激动剂或拮抗剂的定义明确的被芳基和/或杂芳基取代的吲哚。因此,本文所述的化合物可用于治疗多种与1-磷酸-鞘氨醇调变相关的疾病。
USPTO Abstract
本发明提供可用作1-磷酸-鞘氨醇激动剂或拮抗剂的定义明确的被芳基和/或杂芳基取代的吲哚。因此,本文所述的化合物可用于治疗多种与1-磷酸-鞘氨醇调变相关的疾病。
Drugs covered by this patent
- Mayzent (SIPONIMOD) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.